Company: IPCX
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076625
Chunk: 80

Company: Inflection Point Acquisition Corp. III
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 8
Chunk 80
---
 in a private placement to the Sponsor and Cantor, generating gross
proceeds of $7,400,000.

Following the Initial Public Offering, the full
exercise of the over-allotment option, and the sale of the Private Units, a total of $253,000,000 was placed in the Trust Account. We
incurred $17,305,941, consisting of $4,400,000 of cash underwriting fee, $12,045,000 of deferred underwriting fee, and $860,941 of other
offering costs. 

16

For the six months ended June 30, 2025, cash
used in operating activities was $727,928. Net loss of $1,297,717 was affected by interest earned on marketable securities held in the
Trust Account of $957,808 and compensation expense of $2,581,854. Changes in operating assets and liabilities used $1,054,257 of cash
for operating activities.  

For the period from January 31, 2024 (inception)
through June 30, 2024, cash used in operating activities was $0.

As of June 30, 2025, we had marketable securities
held in the Trust Account of $253,957,808. We intend to use substantially all of the funds held in the Trust Account, including any amounts
representing interest earned on the Trust Account (less income taxes payable), to complete our Business Combination. We may withdraw
interest or dividends earned on the funds held in the Trust Account for Permitted Withdrawals. To the extent that our share capital or
debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account
will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our
growth strategies.  

As of June 30, 2025, we had cash of $1,509,466.
We intend to use the funds held outside the Trust Account plus permitted withdrawals primarily to identify and evaluate target businesses,
perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective
target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses,
and structure, negotiate and complete a Business Combination.

In order to fund working capital deficiencies
or finance transaction costs in connection with a Business Combination, the Sponsor